| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 4.3% | $5,816,042 | 1,138,436 | BlackRock, Inc. | 30 Sep 2025 |
As of 30 Sep 2025, 75 institutional investors reported holding 5,138,582 shares of AVITA Medical, Inc. - Common Stock (RCEL). This represents 19% of the company’s total 26,475,256 outstanding shares.
The largest institutional shareholders of AVITA Medical, Inc. - Common Stock (RCEL) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 5.2% | 1,365,477 | -5.9% | 0% | $6,977,588 |
| BlackRock, Inc. | 4.3% | 1,138,436 | -40% | 0% | $5,817,407 |
| STATE STREET CORP | 1.6% | 423,308 | -20% | 0% | $2,163,104 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 331,463 | -46% | 0% | $1,694,484 |
| NORTHERN TRUST CORP | 0.65% | 172,778 | -33% | 0% | $882,895 |
| MILLENNIUM MANAGEMENT LLC | 0.5% | 132,709 | -64% | 0% | $678,143 |
| AQR CAPITAL MANAGEMENT LLC | 0.45% | 119,288 | +444% | 0% | $609,562 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.45% | 118,004 | +214% | 0.01% | $603,000 |
| GOLDMAN SACHS GROUP INC | 0.44% | 116,845 | +25% | 0% | $597,078 |
| Divisadero Street Capital Management, LP | 0.38% | 100,000 | 0.02% | $511,000 | |
| MORGAN STANLEY | 0.37% | 97,242 | -56% | 0% | $496,906 |
| HRT FINANCIAL LP | 0.35% | 93,026 | 0% | $475,000 | |
| UBS Group AG | 0.28% | 75,400 | -82% | 0% | $385,294 |
| JANE STREET GROUP, LLC | 0.27% | 70,427 | -19% | 0% | $359,882 |
| BANK OF AMERICA CORP /DE/ | 0.23% | 62,139 | -0.66% | 0% | $317,530 |
| NATIONAL BANK OF CANADA /FI/ | 0.22% | 58,900 | 0% | $300,979 | |
| STRS OHIO | 0.18% | 47,700 | +234% | 0% | $243,747 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.17% | 45,634 | -47% | 0% | $233,190 |
| MARSHALL WACE, LLP | 0.16% | 42,807 | -44% | 0% | $218,744 |
| Nuveen, LLC | 0.16% | 41,962 | -29% | 0% | $214,426 |
| Quantinno Capital Management LP | 0.16% | 41,483 | +228% | 0% | $211,978 |
| RHUMBLINE ADVISERS | 0.14% | 38,330 | -9.1% | 0% | $195,859 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 35,193 | +1.8% | 0% | $179,836 |
| GABELLI FUNDS LLC | 0.13% | 35,000 | 0% | 0% | $178,850 |
| Bank of New York Mellon Corp | 0.12% | 30,992 | -44% | 0% | $158,369 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,206 | $4,611 | -$672 | $3.45 | 5 |
| 2025 Q3 | 5,138,582 | $26,258,248 | -$13,168,453 | $5.11 | 75 |
| 2025 Q2 | 7,684,503 | $40,650,943 | +$2,876,263 | $5.29 | 79 |
| 2025 Q1 | 7,044,428 | $57,343,339 | +$2,375,906 | $8.14 | 74 |
| 2024 Q4 | 6,454,868 | $82,623,830 | +$4,559,187 | $12.80 | 72 |
| 2024 Q3 | 6,095,789 | $65,347,676 | +$515,283 | $10.72 | 67 |
| 2024 Q2 | 6,099,329 | $48,306,700 | -$15,647,217 | $7.92 | 68 |
| 2024 Q1 | 7,319,846 | $117,332,190 | +$4,381,511 | $16.03 | 81 |
| 2023 Q4 | 7,095,304 | $97,348,681 | -$14,976,745 | $13.72 | 83 |
| 2023 Q3 | 8,129,935 | $118,780,112 | +$7,346,625 | $14.61 | 80 |
| 2023 Q2 | 7,611,611 | $129,472,974 | +$30,265,942 | $17.01 | 80 |
| 2023 Q1 | 5,906,388 | $82,511,505 | +$21,157,921 | $13.97 | 72 |
| 2022 Q4 | 4,410,243 | $29,107,642 | +$1,258,474 | $6.60 | 51 |
| 2022 Q3 | 4,306,669 | $22,694,330 | -$3,509,090 | $5.27 | 42 |
| 2022 Q2 | 5,060,740 | $24,039,067 | -$9,600,413 | $4.75 | 48 |
| 2022 Q1 | 6,867,607 | $58,179,804 | -$8,054,352 | $8.48 | 65 |
| 2021 Q4 | 7,465,802 | $89,556,714 | -$12,879,940 | $11.98 | 59 |
| 2021 Q3 | 8,337,406 | $148,034,944 | -$7,922,344 | $17.72 | 67 |
| 2021 Q2 | 8,754,978 | $179,543,764 | +$37,847,379 | $20.52 | 69 |
| 2021 Q1 | 7,070,182 | $139,896,335 | +$55,735,706 | $19.82 | 59 |
| 2020 Q4 | 4,168,156 | $77,440,780 | +$11,413,265 | $18.58 | 49 |
| 2020 Q3 | 3,433,525 | $86,331,057 | +$50,603,668 | $25.16 | 40 |
| 2020 Q2 | 1,409,579 | $43,046,283 | +$43,046,283 | $30.53 | 31 |
| 2020 Q1 | 300 | $6,000 | $20.00 | 1 | |
| 2019 Q4 | 300 | $6,000 | $20.00 | 1 | |
| 2019 Q3 | 300 | $6,000 | $20.00 | 1 | |
| 2019 Q2 | 300 | $6,000 | $20.00 | 1 | |
| 2019 Q1 | 300 | $6,000 | $20.00 | 1 |